News

Congress failed to reach a decision on Zika funding today as a new study reveals that the epidemic is expected to last well into 2019.

With the 2016 Rio Olympic Games less than one month away, the Centers for Disease Control and Prevention (CDC) released a statement summarizing their assessment of the risk of Zika importation by those returning from the summer Games.

A new technological approach to genome editing that can clear latent and productive herpesvirus infections from human cells in vitro could eventually lead to a potent prophylactic.

The US Food and Drug Administration (FDA) just approved the first test to detect human papillomavirus (HPV) using specific samples.

Due to an ongoing investigation of a multistate outbreak linked to contaminated liquid docusate products, the Centers for Disease Control and Prevention (CDC) advised healthcare providers against the use of these products.

A molecule in green tea, known as epigallocatechin (EGCG), blocks the entry of a Brazilian strain of Zika virus into host cells, and may hold potential benefit for prevention of Zika virus infections, a new study has found.

Although researchers have made progress in identifying potential medical countermeasures to hinder the spread of Middle East respiratory syndrome (MERS), the virus is still spreading.

As Congress debates action to combat the virus, a patient in Salt Lake County, Utah has lost the fight against Zika.

According to a recent study, screening for microcephaly can no longer adequately determine whether or not a baby has suffered abnormalities due to a congenital Zika infection.

Since May, there have been nine confirmed cases, with one fatality, in Los Angeles, Long Beach, and Orange counties. According to the California Department of Public Health (CDPH), most of those infected have been gay and/or bisexual men.

Both inappropriate catheter use and rates of catheter-associated urinary tract infections (UTIs) can be reduced in the non-intensive care unit (ICU) setting.

In a recent clinical alert, the Centers for Disease Control and Prevention (CDC) warned US healthcare facilities about Candida auris, an emerging multidrug-resistant (MDR) yeast that is causing severe, and sometimes fatal, healthcare-associated infections.

Because protection against this mysterious virus is essential, as is a need to understand it, researchers have been using the resources that are available to learn more about Zika and how to prevent infection.

Exactly how to screen for and, thus, diagnose Zika virus remains a bit of a moving target for clinicians as the risk for localized transmission of the mosquito-borne disease rises for some parts of the United States with the arrival of summer.

One month before the summer Olympics are set to be begin in Rio de Janeiro, Brazil amid the threat of the Zika virus, another health threat has been identified in the city.

A new study may uncover the mystery behind why the Ebola virus disease is fatal to only some, and lead to pathways to new treatments.

Researchers have found that Aedes aegypti mosquitoes infected with these bacteria were less likely to become infected with the Zika virus after feeding, and that those who did become infected were unable to transmit the virus in their saliva.

A new bacteriophage (phage) treatment-based approach to fighting Clostridium difficile (C. difficile) colonization and infection may one day provide for effective treatment against this potentially lethal disease.

“We really won’t be able to protect the American people to the extent that we can, from the technology standpoint, without that funding.” states Stephen Redd, MD, director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC).

As the incidence of tuberculosis (TB) continues to decline in low-prevalence settings such as the United States, there is some concern within the infectious disease/public health field that clinicians may not be aware of the latest diagnostic technologies available to screen for the disease.

The US Food and Drug Administration just approved a new regimen to treat the six major forms of chronic hepatitis C (HCV).

A multistate outbreak of Burkholderia cepacia infections might be linked to contaminated liquid docusate products in one of the states.

When a health emergency erupts somewhere in the world, the Centers for Disease Control and Prevention (CDC) quickly sends its new Global Rapid Response Team (Global RRT).

On Thursday, June 23, 2016, House Republicans approved a bill which included a $1.1 billion fund to combat Zika. But, there’s one big drawback, according to Democrats.

This review article provides guidance for clinicians that have been struggling with the most effective way to treat chronic hepatitis B virus (HBV) infection in children and adolescents.

A new case report about the death of a woman from rabies emphasizes the importance of rabies awareness and education among the public.

During a session at the ASM Microbe 2016 conference on Monday, June 20, 2016, a Centers for Disease Control and Prevention officer presented data on the investigation of the Elizabethkingia anophelis outbreak that started in Wisconsin and spread to two other states.

The Center for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) has voted against the use of the live attenuated influenza vaccine (LAIV), or “nasal spray,” for the 2016-2017 flu season.

The number of physicians and nurse practitioners aware of HIV pre-exposure prophylaxis (PrEP) and its potential benefits has increased dramatically in the years since it was first introduced to the market.

A therapeutic vaccine for genital herpes has the potential to reduce viral activity as well as decrease the number of days of recurrent herpes, as observed in a phase II clinical trial.